Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Clinical and Experimental Rheumatology|July 20, 2023
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for RheumatologyDuygu Temiz Karadag, Yasemin Yalcinkaya, Ali Akdogan, et al.Annals of the Rheumatic Diseases|April 26, 2012
Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?Nasim Ahmed Khan, Horace Jack Spencer, Essam Ahmed Abda, et al.Annals of the Rheumatic Diseases|September 13, 2022
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registriesManuel Pombo-Suarez, Carlos Sanchez-Piedra, Juan Gómez-Reino, et al.Clinical and Experimental Rheumatology|December 7, 2021
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infectionPilar Brito-Zerón, Nihan Acar-Denizli, Vasco C Romão, et al.Rheumatology Advances in Practice|September 22, 2022
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational studyHaner Direskeneli, Omer Karadag, Askin Ates, et al.Journal of Clinical Medicine|December 17, 2024
Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing SpondylitisSadettin Uslu, Semih Gülle, Gercek Sen, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 19, 2023
Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of TofacitinibNevsun Inanc, Kerem Y Abacar, Mehmet A Ozturk, et al.Clinical and Experimental Rheumatology|November 28, 2022
Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndromeNevsun Inanc, Belchin Kostov, Roberta Priori, et al.Clinical and Experimental Rheumatology|December 21, 2022
Characterisation of the coexistence between sarcoidosis and Sjögren's syndrome. Analysis of 43 patientsAlejandra Flores-Chavez, Wan-Fai Ng, Alessia Alunno, et al.Annals of the Rheumatic Diseases|June 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaborationKim Lauper, Michele Iudici, Denis Mongin, et al.Pageof 7